Field Medical | First-in-Human 6-Month Data Selected for Late-Breaking Clinical Trial at VT Symposium 2025

The company will be featured across three sessions, including first-in-human six-month outcomes from its FieldForce™ Ablation System, the first focal contact-force PFA platform designed for VT, a pre-recorded live VT case and translational preclinical research